Document 1ZLgE48QGKoJxKgmb9Ly6zEK
Ares(2020)2818827
From: To: Cc: Subject: Date:
Dear
(CAB-KYRIAKIDES)
@btconnect.com;
(CAB-KYRIAKIDES);
(CAB-KYRIAKIDES)
Re: The Endocrine Society requests meeting with Commissioner for EDC scientists and clinicians
jeudi 28 mai 2020 09:02:26
That is excellent, thank you very much. My colleagues will follow-up as we will need the names and contact details of the participants to invite them to the meeting.
All the best,
From:
@endocrine.org>
Sent: 27 May 2020 23:10
To:
(CAB-KYRIAKIDES)
Cc:
@btconnect.com;
(CAB-KYRIAKIDES);
(CAB-
KYRIAKIDES)
Subject: RE: The Endocrine Society requests meeting with Commissioner for EDC scientists and
clinicians
Dear
Please accept this e-mail as confirmation that the meeting date/time of 26 June at 10:30 via Webex will work quite well for us. I look forward to receiving more details and will follow up separately with a list of participants from our end. In addition to 1 or 2 Endocrine Society staff representatives, we will have up to 4 expert endocrine scientists for total participation of approximately 6 individuals.
With appreciation,
From:
@ec.europa.eu
@ec.europa.eu>
Sent: Monday, May 25, 2020 10:37 AM
To:
@endocrine.org>
Cc:
@btconnect.com;
@ec.europa.eu;
@ec.europa.eu
Subject: Re: The Endocrine Society requests meeting with Commissioner for EDC scientists and
clinicians
Dear
Commissioner Kyriakides would be delighted to meet on 26 June at 10:30 via Webex. Would this date and time suit you?
If you would be available, then my colleagues
will be get back to you with
the details. All the best,
From:
@endocrine.org>
Sent: 13 May 2020 16:43
To:
(CAB-KYRIAKIDES);
(CAB-KYRIAKIDES);
(CAB-KYRIAKIDES)
Cc:
Subject: The Endocrine Society requests meeting with Commissioner for EDC scientists and
clinicians
Dear Commissioner Kyriakides
Endocrine Disrupting Chemicals (EDCs): The Endocrine Society requests meeting with Commissioner for EDC scientists and clinicians
Following our postponed meeting originally scheduled for 20 March, I write on behalf of the Endocrine Society to ask whether it is now possible to schedule a new date for a meeting by video conference with the same small group of EDC expert scientists and clinicians who are members of our Society's EU EDC Task Force.
We would appreciate the opportunity to offer an update of the latest science on EDCs as a contribution to the EU policy decisions currently under debate which will address endocrine disruptors (EDCs), such as the EU Chemicals Strategy for Sustainability and the non-toxic environment programme, as well as the Beating Cancer Action Plan.
In particular, in view of the current health crisis, we draw your attention to the impacts of EDCs on diseases such as diabetes and other health conditions that cause immune system dysfunction and increase our susceptibility to COVID-19 and future pandemic disease. (See links here and here). We therefore believe that reducing our continued exposure to these harmful chemicals is one vital part of preventative measures to protect public health for the future.
We look forward to your response and to our rescheduled meeting at your convenience.
Sincerely,
, SCIENCE POLICY
2055 L STREET NW, SUITE 600, WASHINGTON, DC 20036 T. 202.971.3636 F. 202.736.9705 D.
@ENDOCRINE.ORG endocrine.org